Table 2

PPAR-RE promoter activity in H2122 stable transfectants

Luciferase Units/β-gal
Cell LineBasalCiglitazoneSulindac Sulfide
Neo6,617  ±  1,49311,246  ±  3,25610,242  ±  1,591
PPARγ-1620,236  ±  1,05699,747  ±  7,40053,879  ±  4,097
PPARγ-1858,805  ±  4,778258,823  ±  3,4120136,556  ±  3,516
PPARγ-354,517  ±  3,60891484  ±  31,34899,902  ±  19,766

H2122 cells were stably transfected with retroviruses encoding full-length PPARγ and individual clones were selected for resistance to G-418. Control cells (Neo) were transfected with a retroviral vector lacking an insert. Three clones overexpressing PPARγ and one Neo clone were transiently transfected with the PPAR-RE promoter construct as described in Fig. 2. Cells were stimulated for 24 h with either 10 μ M ciglitazone or 25 μ M sulindac sulfide, and promoter activity normalized to β -gal was determined. Results represent the mean of three independent experiments.